Home > Insider Trading > Matinas Biopharma Holdings Inc. > Profile

Matinas Biopharma Holdings Inc. (MTNB)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Sector: Healthcare

Insider Roster

Edward Neugeboren, Director, 2025-05-02
L Robin Smith, Director, 2025-05-02
Evelyn An D, Director, 2025-05-02

Edward Neugeboren, Director, 2025-05-02
L Robin Smith, Director, 2025-05-02
Evelyn An D, Director, 2025-05-02
D Jerome Jabbour, President and Ceo, 2025-05-02
Keith Murphy, Director, 2025-05-02
K Adam Stern, 2025-04-11
Sanitam Partners Llc, 2025-04-10
J Robert Eide, 2025-04-10
Pembroke & Partners Llc, 2025-04-10
Theresa Matkovits, Chief Development Officer, 2023-12-16
Thomas Hoover, Chief Business Officer, 2023-12-16
A Keith Kucinski, Chief Financial Officer, 2023-12-16
Hui Liu, Chief Technology Officer, 2023-12-16
Iii J. James Ferguson, Chief Medical Officer, 2023-12-16
J Eric Ende, Director, 2023-11-03
Penkus Kathryn Corzo, Director, 2023-11-03
Matthew Wikler, Director, 2023-11-03
J Herbert Conrad, Director, 2023-11-03
S James Scibetta, Director, 2023-11-03
Natasha Giordano, Director, 2023-11-03
J Raphael Mannino, Chief Scientific Officer, 2021-12-16
G Patrick Lepore, Director, 2020-11-10
Gary Gaglione, Chief Financial Officer, 2018-05-02
Dominick Dipaolo, Sr. Vp-Quality & Manufacturing, 2018-05-02
Roelof Rongen, Chief Executive Officer, 2017-09-11
Stefano Ferrari, Director, 2017-09-07
Gjg Capital, Llc, Other, 2017-07-03
Jennifer Lorenzo, Other, 2017-07-03
Gjg Life Sciences, Llc, Other, 2017-07-03
F Douglas Kling, See Remarks, 2017-03-01
A. Abdel Fawzy, See Remarks, 2017-03-01

Show All Insiders (31)

Hedge Fund Popularity

Display

13F filing is ongoing

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2025, 8:54pm based on SEC 13F filings Last update: November 14, 2025, 8:54pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Renaissance Technologies Jim Simons	28,270	$53,430	+15%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Stern Director	$0.83	20,000	$16,600.00	3,301,983	2020-08-21	Filing
Lepore Director	$0.73	100,000	$73,050.00	400,000	2020-05-14	Filing
Stern Director	$0.65	10,000	$6,500.00	10,000	2020-03-17	Filing
Jabbour Officer, Director	$0.65	10,000	$6,500.00	799,511	2020-03-17	Filing
Kucinski Officer	$1.23	58,000	$71,160.20	94,500	2019-11-25	Filing

Institutional Investors' Holdings

Filing Period: Filing is Ongoing

No.	Name	Shares	Value	% Port
1.	Vanguard Group Inc	59,725	$34,998	0%
2.	Holos Integrated Wealth Llc	32,480	$20,138	0.01%
3.	Ubs Group Ag	607	$356	0%
4.	Farther Finance Advisors, Llc	422	$247	0%
5.	Vision Financial Markets Llc	40	$24	0%

News See All

Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203

Matinas BioPharma Holdings, Inc. (NYSE:MTNB) is a clinical-stage biopharmaceutical company developing oral anti-infective therapies using its proprietary lipid nanocrystal (LNC) platform.

Keep Reading →

September 23rd, 2025 - News

15 Best Biotech Penny Stocks to Invest in Right Now

Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.

Keep Reading →

September 21st, 2025 - Hedge Funds News

12 Best Day Trading Stocks To Buy

Over the past few years, the rise of a new generation of stock traders that like to engage in risky bets, coupled with the advent of stock trading mobile applications, has given increased popularity to...

Keep Reading →

November 9th, 2023 - Hedge Funds News

12 Hot Penny Stocks On the Rise

Penny stocks usually trade under $5 and are favored by new investors or market participants who prefer day trading.

Keep Reading →

January 20th, 2023 - Hedge Funds News

10 Best Biotech Penny Stocks To Buy Now

Like all sectors of the economy right now, the biotech sector is going through a lot of pain.

Keep Reading →

June 20th, 2022 - Hedge Funds News

Matinas Biopharma Holdings, Inc. (MTNB) Fell Out Of Favor With Hedge Funds

After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...

Keep Reading →

December 2nd, 2020 - Hedge Funds News